+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05553886

Phase III Study of S086 Tablets Compared to Sacubitril Valsartan Sodium for Treating Chronic Heart Failure with Reduced Ejection Fraction

Led by Shenzhen People's Hospital · Updated on 2022-11-03

5

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter, randomized, double-blind phase III trial to evaluate the effectiveness and safety of S086 tablets in patients with chronic heart failure who have reduced ejection fraction HFrEF. This study compares S086 tablets to an active control drug, sacubitril valsartan sodium tablets, to see if S086 is not less effective. The trial is led by Shenzhen Peoples Hospital and aims to provide important information for treating this condition. Participants in the trial receive either S086 tablets in doses of 60mg, 120mg, 180mg, or 240mg or sacubitril valsartan sodium tablets in doses of 50mg or 100mg. The study uses a quadruple-blind design where neither the participants nor the researchers know which treatment is given. The treatments are administered in a parallel controlled manner across multiple centers. The primary evaluation occurs at 28 weeks, focusing on the efficacy comparison between the two drugs. During the study, participants will be monitored closely to assess treatment effects and safety. Researchers will measure heart function and related biomarkers to determine the efficacy of the treatments. Participants will continue their regular heart failure therapy during the trial with stable dosing before enrollment. The study includes detailed eligibility screening and ongoing safety assessments throughout the treatment period until the study ends in 2026.

CONDITIONS

Brief Title

S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction

Research Team

J

junbo he

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here